Article
ErbB4 deletion predisposes to development of metabolic syndrome in mice.
American journal of physiology. Endocrinology and metabolism - 1 Oct 2018
Zeng Fenghua, Wang Yinqiu, Kloepfer Lance A, Wang Suwan, Harris Raymond C
Abstract excerpt
ErbB4, a member of the EGF receptor family, plays a variety of roles in physiological and pathological states. Genetic studies have indicated a link between ErbB4 and type 2 diabetes and obesity, but its role in metabolic syndrome (MetS) has not been reported. In the current study we found that mice with ErbB4 deletion developed MetS after 24 wk on a medium-fat diet (MFD), as indicated by development of obesity,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
